<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <constitutionalAuthorityStatementText><![CDATA[<pre>From the Congressional Record Online through the Government Publishing Office [<a href='http://www.gpo.gov'>www.gpo.gov</a>]By Ms. DeLAURO:H.R. 931.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8, Clause 3 and Article I, Section 8,Clause 18 of the United States Constitution.[Page H1036]</pre>]]></constitutionalAuthorityStatementText>
    <sponsors>
      <item>
        <identifiers>
          <bioguideId>D000216</bioguideId>
          <gpoId>7868</gpoId>
          <lisID>281</lisID>
        </identifiers>
        <district>3</district>
        <byRequestType />
        <fullName>Rep. DeLauro, Rosa L. [D-CT-3]</fullName>
        <firstName>ROSA</firstName>
        <state>CT</state>
        <bioguideId>D000216</bioguideId>
        <middleName />
        <party>D</party>
        <lastName>DELAURO</lastName>
      </item>
    </sponsors>
    <committeeReports />
    <titles>
      <item>
        <chamberCode />
        <title>HEAL Act</title>
        <chamberName />
        <titleType>Short Titles as Introduced</titleType>
        <parentTitleType />
      </item>
      <item>
        <chamberCode />
        <title>Helping Effective Antibiotics Last Act of 2015</title>
        <chamberName />
        <titleType>Short Titles as Introduced</titleType>
        <parentTitleType />
      </item>
      <item>
        <chamberCode />
        <title>To provide for approval of certain drugs and biological products indicated for use in a well-defined population of patients in order to address increases in bacterial resistance to drugs and biological products, and for other purposes.</title>
        <chamberName />
        <titleType>Official Title as Introduced</titleType>
        <parentTitleType />
      </item>
      <item>
        <chamberCode />
        <title>HEAL Act</title>
        <chamberName />
        <titleType>Display Title</titleType>
        <parentTitleType />
      </item>
    </titles>
    <laws />
    <createDate>2015-02-13T06:14:12Z</createDate>
    <recordedVotes />
    <billNumber>931</billNumber>
    <originChamber>House</originChamber>
    <committees>
      <billCommittees>
        <item>
          <subcommittees>
            <item>
              <systemCode>hsif14</systemCode>
              <activities>
                <item>
                  <date>2015-02-13T14:52:33Z</date>
                  <name>Referred to</name>
                </item>
              </activities>
              <name>Health Subcommittee</name>
            </item>
          </subcommittees>
          <chamber>House</chamber>
          <systemCode>hsif00</systemCode>
          <activities>
            <item>
              <date>2015-02-12T15:06:45Z</date>
              <name>Referred to</name>
            </item>
          </activities>
          <type>Standing</type>
          <name>Energy and Commerce Committee</name>
        </item>
      </billCommittees>
    </committees>
    <relatedBills />
    <updateDate>2016-11-02T21:26:03Z</updateDate>
    <summaries>
      <billSummaries>
        <item>
          <versionCode>00</versionCode>
          <actionDate>2015-02-12</actionDate>
          <text><![CDATA[<p><b>Helping Effective Antibiotics Last Act of 2015 or the HEAL Act</b></p> <p>This bill amends the Federal Food, Drug, and Cosmetic Act to allow the Food and Drug Administration (FDA) to approve an antibacterial drug or biological product that is intended to treat a serious or life-threatening condition only for treating a well-defined population of patients. To be approved, the antibacterial product must produce superior outcomes over available therapies in the well-defined patient population.</p> <p>A product approved by this pathway must include in its prescribing information the population of patients expected to benefit from using the product and the method for identifying members of that population. The FDA must require each product to have a risk evaluation and mitigation strategy.</p> <p>The Centers for Disease Control and Prevention must monitor changes to bacterial drug resistance and changes to patient outcomes caused by bacterial drug resistance.</p> <p>Upon approval of antibacterial products, the FDA must identify susceptibility test interpretive criteria (the drug concentrations where a type of bacteria is categorized as susceptible, intermediate, or resistant) and update the criteria as needed based upon evidence of changes in patient outcomes. </p> <p>To be eligible for an exclusivity period extension, a qualified infectious disease product must be demonstrated to produce superior outcomes over available therapies.</p> The FDA must issue guidance on the development of target product profiles for antibacterial drugs.]]></text>
          <lastSummaryUpdateDate>2015-07-15T22:06:55Z</lastSummaryUpdateDate>
          <actionDesc>Introduced in House</actionDesc>
          <name>Introduced in House</name>
          <updateDate>2015-02-12T05:00:00Z</updateDate>
        </item>
      </billSummaries>
    </summaries>
    <congress>114</congress>
    <title>HEAL Act</title>
    <calendarNumbers />
    <actions>
      <actionTypeCounts>
        <placeholderTextForH>1</placeholderTextForH>
        <billReferrals>1</billReferrals>
        <introducedInHouse>1</introducedInHouse>
        <introducedInTheHouse>1</introducedInTheHouse>
      </actionTypeCounts>
      <item>
        <actionDate>2015-02-13</actionDate>
        <committee>
          <systemCode>hsif14</systemCode>
          <name>Health Subcommittee</name>
        </committee>
        <links />
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2015-02-12</actionDate>
        <text>Referred to the House Committee on Energy and Commerce.</text>
        <type>IntroReferral</type>
        <committee>
          <systemCode>hsif00</systemCode>
          <name>Energy and Commerce Committee</name>
        </committee>
        <links />
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <actionCode>H11100</actionCode>
      </item>
      <item>
        <actionDate>2015-02-12</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <committee />
        <links />
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <actionCode>Intro-H</actionCode>
      </item>
      <item>
        <actionDate>2015-02-12</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <committee />
        <links />
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <actionCode>1000</actionCode>
      </item>
      <actionByCounts>
        <houseOfRepresentatives>4</houseOfRepresentatives>
      </actionByCounts>
    </actions>
    <amendments />
    <cboCostEstimates />
    <introducedDate>2015-02-12</introducedDate>
    <latestAction>
      <text>Referred to the Subcommittee on Health.</text>
      <actionDate>2015-02-13</actionDate>
      <links />
    </latestAction>
    <subjects>
      <billSubjects>
        <legislativeSubjects>
          <item>
            <name>Administrative law and regulatory procedures</name>
          </item>
          <item>
            <name>Administrative remedies</name>
          </item>
          <item>
            <name>Consumer affairs</name>
          </item>
          <item>
            <name>Department of Health and Human Services</name>
          </item>
          <item>
            <name>Drug safety, medical device, and laboratory regulation</name>
          </item>
          <item>
            <name>Food and Drug Administration (FDA)</name>
          </item>
          <item>
            <name>Government information and archives</name>
          </item>
          <item>
            <name>Health information and medical records</name>
          </item>
          <item>
            <name>Infectious and parasitic diseases</name>
          </item>
          <item>
            <name>Licensing and registrations</name>
          </item>
          <item>
            <name>Medical research</name>
          </item>
          <item>
            <name>Prescription drugs</name>
          </item>
        </legislativeSubjects>
        <policyArea>
          <name>Health</name>
        </policyArea>
      </billSubjects>
    </subjects>
    <cosponsors>
      <item>
        <fullName>Rep. Slaughter, Louise McIntosh [D-NY-25]</fullName>
        <lastName>SLAUGHTER</lastName>
        <bioguideId>S000480</bioguideId>
        <party>D</party>
        <district>25</district>
        <sponsorshipWithdrawnDate />
        <state>NY</state>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <sponsorshipDate>2015-02-12</sponsorshipDate>
        <middleName>M.</middleName>
        <firstName>LOUISE</firstName>
        <identifiers>
          <bioguideId>S000480</bioguideId>
          <lisID>1069</lisID>
          <gpoId>8089</gpoId>
        </identifiers>
      </item>
      <item>
        <fullName>Rep. Meng, Grace [D-NY-6]</fullName>
        <lastName>Meng</lastName>
        <bioguideId>M001188</bioguideId>
        <party>D</party>
        <district>6</district>
        <sponsorshipWithdrawnDate />
        <state>NY</state>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <sponsorshipDate>2015-02-12</sponsorshipDate>
        <middleName />
        <firstName>Grace</firstName>
        <identifiers>
          <lisID>2148</lisID>
          <gpoId />
          <bioguideId>M001188</bioguideId>
        </identifiers>
      </item>
      <item>
        <fullName>Rep. Ellison, Keith [D-MN-5]</fullName>
        <lastName>Ellison</lastName>
        <bioguideId>E000288</bioguideId>
        <party>D</party>
        <district>5</district>
        <sponsorshipWithdrawnDate />
        <state>MN</state>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <sponsorshipDate>2015-02-24</sponsorshipDate>
        <middleName />
        <firstName>Keith</firstName>
        <identifiers>
          <lisID>1857</lisID>
          <bioguideId>E000288</bioguideId>
          <gpoId>8005</gpoId>
        </identifiers>
      </item>
      <item>
        <fullName>Rep. Grijalva, Raul M. [D-AZ-3]</fullName>
        <lastName>Grijalva</lastName>
        <bioguideId>G000551</bioguideId>
        <party>D</party>
        <district>3</district>
        <sponsorshipWithdrawnDate />
        <state>AZ</state>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <sponsorshipDate>2015-02-24</sponsorshipDate>
        <middleName>M.</middleName>
        <firstName>Raul</firstName>
        <identifiers>
          <gpoId>7804</gpoId>
          <lisID>1708</lisID>
          <bioguideId>G000551</bioguideId>
        </identifiers>
      </item>
      <item>
        <fullName>Rep. DeFazio, Peter A. [D-OR-4]</fullName>
        <lastName>DEFAZIO</lastName>
        <bioguideId>D000191</bioguideId>
        <party>D</party>
        <district>4</district>
        <sponsorshipWithdrawnDate />
        <state>OR</state>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <sponsorshipDate>2015-03-16</sponsorshipDate>
        <middleName>A.</middleName>
        <firstName>PETER</firstName>
        <identifiers>
          <lisID>279</lisID>
          <bioguideId>D000191</bioguideId>
          <gpoId>8117</gpoId>
        </identifiers>
      </item>
      <item>
        <fullName>Rep. Norton, Eleanor Holmes [D-DC-At Large]</fullName>
        <lastName>NORTON</lastName>
        <bioguideId>N000147</bioguideId>
        <party>D</party>
        <district>0</district>
        <sponsorshipWithdrawnDate />
        <state>DC</state>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <sponsorshipDate>2015-04-14</sponsorshipDate>
        <middleName>HOLMES</middleName>
        <firstName>ELEANOR</firstName>
        <identifiers>
          <bioguideId>N000147</bioguideId>
          <lisID>868</lisID>
          <gpoId>7871</gpoId>
        </identifiers>
      </item>
      <item>
        <fullName>Rep. McCollum, Betty [D-MN-4]</fullName>
        <lastName>MCCOLLUM</lastName>
        <bioguideId>M001143</bioguideId>
        <party>D</party>
        <district>4</district>
        <sponsorshipWithdrawnDate />
        <state>MN</state>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <sponsorshipDate>2015-06-23</sponsorshipDate>
        <middleName />
        <firstName>BETTY</firstName>
        <identifiers>
          <lisID>1653</lisID>
          <gpoId>8004</gpoId>
          <bioguideId>M001143</bioguideId>
        </identifiers>
      </item>
    </cosponsors>
    <notes />
    <billType>HR</billType>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

